The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the organoids and spheroids industry?
The increase in demand for cell therapy and tissue engineering is expected to propel the growth of the organoids and spheroids market going forward. Cell therapy and tissue engineering involve using living cells or engineered tissues to replace, repair, or regenerate damaged tissues and organs in the body. The demand for cell therapy and tissue engineering is rising due to their potential to regenerate damaged tissues and treat previously incurable conditions, offering innovative solutions in regenerative medicine. Organoids and spheroids are utilized in cell therapy and tissue engineering for modeling complex tissues and testing therapeutic approaches in vitro. For instance, in February 2023, according to Cell & Gene, a US-based online resource for research scholars, there were 27 FDA-approved cell and gene therapies (CGTs), accounting for about 8% of the 340 approved biologics in 2022, an increase from 22 approved in 2021. This rising demand for cell therapy and tissue engineering is anticipated to fuel the growth of the organoids and spheroids market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=18421&type=smp
What is the estimated market size of the organoids and spheroids sector by 2029, based on current forecasts?
The organoids and spheroids market size has grown exponentially in recent years. It will grow from $1.16 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 24.6%. The growth in the historic period can be attributed to rapid progress in stem cell research and 3d cell culture technologies, increased funding and investments, rise in chronic diseases, increased use of organoids and spheroids in drug screening and toxicology studies, progress in regenerative medicine and personalized medicine approaches, favorable regulatory frameworks supporting the use of advanced cell culture models in research.
The organoids and spheroids market size is expected to see exponential growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 24.4%. The growth in the forecast period can be attributed to continued technological advancements, expansion of personalized medicine, enhanced applications in cancer research, ethical and regulatory evolution, growth in commercial products and services based on organoid and spheroid technologies, increased educational initiatives to train researchers in organoid and spheroid technologies. Major trends in the forecast period include integration with advanced technologies, expansion of high-throughput screening methods using organoids for drug discovery, 3D bioprinting and bio fabrication, increasing use of organoids for modeling various cancers, and integration of organoids with microfluidic systems.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=18421&type=smp
Who are the top players in the organoids and spheroids market?
Major companies operating in the organoids and spheroids market are Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, StemCell Technologies Canada Inc., Greiner Bio-One International AG, Promega Corporation, Molecular Devices LLC, American Type Culture Collection (ATCC), Mimetas B.V., InSphero AG, HUB Organoids, Emulate Inc., 3D Biomatrix Inc., Prellis Biologics Inc., 3D Biotek LLC, DefiniGEN Limited, Visikol Inc., Organovo Holdings Inc., Cellesce Ltd., AMS Biotechnology (Europe) Limited
What are the major trends in the organoids and spheroids market?
Major companies operating in the organoids and spheroids market are focused on developing advanced solutions, such as single-particle dispensers, to improve precision in cell handling and enhance the reproducibility of research outcomes. Single-particle dispensers are precision instruments designed to isolate and dispense individual cells or particles, enabling accurate control and handling in research and diagnostic applications. For instance, in July 2024, SEED Biosciences, a Switzerland-based biotechnology company, introduced Dispen3D, a revolutionary tool designed for the accurate dispensing of individual spheroids and organoids, marking a significant breakthrough in the handling of 3D cellular models. Researchers can now swiftly and precisely transfer single spheroids into multi-well plates with this novel dispenser, which automates the procedure and ensures monoclonality, which is crucial for drug discovery and customized treatment. Dispen3D delicately treats fragile cells while maintaining their structural integrity and vitality by operating at low pressures. Its user-friendly design makes it simple to implement in a variety of research contexts, satisfying the growing need for cutting-edge instruments in the biological sciences.
Which geography holds the highest organoids and spheroids market share?
North America was the largest region in the organoids and spheroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoids and spheroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/organoids-and-spheroids-global-market-report
How do different segments contribute to the overall expansion of the organoids and spheroids market?
The organoids and spheroids market covered in this report is segmented –
1) By Type: Organoids, Spheroids
2) By Method: Extracellular Matrix Scaffold Method, Spinning Bioreactor Method, Hanging Drop Method, Low Adherent Culture Plate Method, Magnetic levitation Method, Other Methods
3) By Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity And Efficacy Testing
4) By End User: Biotechnology And Pharmaceutical Industry, Academic And Research Institutes, Hospitals And Diagnostic Centers
Subsegments:
1) By Organoids: Intestinal Organoids, Liver Organoids, Brain Organoids, Kidney Organoids, Lung Organoids, Pancreatic Organoids, Cardiac Organoids, Retinal Organoids, Tumor Organoids, Organoids For Disease Modeling
2) By Spheroids: Cancer Spheroids, Neural Spheroids, Cardiac Spheroids, Liver Spheroids, Muscle Spheroids, Endothelial Spheroids, Stem Cell-Derived Spheroids, 3D Cell Culture Spheroids
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18421
What defines the structure and scope of the organoids and spheroids market?
Organoids and spheroids are 3D cell culture systems that mimic the structure and function of organs and tissues. Organoids are miniaturized and simplified versions of organs derived from stem cells, while spheroids are spherical clusters of cells that can represent tumor microenvironments or tissue models. These models are used for research in disease modeling, and drug testing.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
